330 related articles for article (PubMed ID: 12391164)
1. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.
Westendorf JJ; Zaidi SK; Cascino JE; Kahler R; van Wijnen AJ; Lian JB; Yoshida M; Stein GS; Li X
Mol Cell Biol; 2002 Nov; 22(22):7982-92. PubMed ID: 12391164
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation.
Schroeder TM; Kahler RA; Li X; Westendorf JJ
J Biol Chem; 2004 Oct; 279(40):41998-2007. PubMed ID: 15292260
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.
Jensen ED; Schroeder TM; Bailey J; Gopalakrishnan R; Westendorf JJ
J Bone Miner Res; 2008 Mar; 23(3):361-72. PubMed ID: 17997710
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
6. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
8. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor.
Xiao H; Hasegawa T; Isobe K
J Biol Chem; 2000 Jan; 275(2):1371-6. PubMed ID: 10625687
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Hiranabe-Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Ann N Y Acad Sci; 1999; 886():195-9. PubMed ID: 10667218
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
Richon VM; Sandhoff TW; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression.
Senawong T; Peterson VJ; Avram D; Shepherd DM; Frye RA; Minucci S; Leid M
J Biol Chem; 2003 Oct; 278(44):43041-50. PubMed ID: 12930829
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA).
Marks PA
Cell Cycle; 2004 May; 3(5):534-5. PubMed ID: 15020838
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription.
Radkov SA; Touitou R; Brehm A; Rowe M; West M; Kouzarides T; Allday MJ
J Virol; 1999 Jul; 73(7):5688-97. PubMed ID: 10364319
[TBL] [Abstract][Full Text] [Related]
14. Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression.
Lamour V; Detry C; Sanchez C; Henrotin Y; Castronovo V; Bellahcène A
J Biol Chem; 2007 Dec; 282(50):36240-9. PubMed ID: 17956871
[TBL] [Abstract][Full Text] [Related]
15. Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKC epsilon signaling pathway.
Kim YK; Han JW; Woo YN; Chun JK; Yoo JY; Cho EJ; Hong S; Lee HY; Lee YW; Lee HW
Oncogene; 2003 Sep; 22(38):6023-31. PubMed ID: 12955081
[TBL] [Abstract][Full Text] [Related]
16. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.
Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A
Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908
[TBL] [Abstract][Full Text] [Related]
17. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
19. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition.
Noh EJ; Lee JS
Biochem Biophys Res Commun; 2003 Oct; 310(2):267-73. PubMed ID: 14521905
[TBL] [Abstract][Full Text] [Related]
20. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.
Kang JS; Alliston T; Delston R; Derynck R
EMBO J; 2005 Jul; 24(14):2543-55. PubMed ID: 15990875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
